Individualized rituximab therapy (B cell- and anti-PLA2R antibody-guided)

Research studies on Individualized rituximab therapy (B cell- and anti-PLA2R antibody-guided) - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.